Literature DB >> 22281902

Combining diagnostic procedures for the management of leishmaniasis in areas with high prevalence of Leishmania guyanensis.

Ednelza de Almeida Benicio1, Ellen Pricilla Nunes Gadelha, Anette Talhari, Roberto Moreira da Silva, Luis Carlos Ferreira, Mayara Cristina Cordeiro dos Santos, Marcelo Távora Mira, Cintia Mara Costa de Oliveira, Carolina Talhari, Sinésio Talhari, Paulo Roberto Machado, Albert Schriefer.   

Abstract

BACKGROUND: The Amazon region corresponds to approximately 40% of the cases of leishmaniasis in Brazil. We report a prospective study with 180 patients conducted in a health care unit that diagnoses 10% of the cases of leishmaniasis in the Brazilian Amazon. The study addresses how a combination of procedures improves diagnosis in areas with high prevalence of Leishmania guyanensis.
OBJECTIVES: to evaluate diagnostic methods in areas with high prevalence of Leishmania guyanensis.
METHODS: All subjects were amastigote-positive by direct microscopic examination of lesion scarifications. We conducted skin biopsy and histopathology, polymerase chain reaction and parasite cultivation.
RESULTS: Polymerase chain reaction detected almost ninety percent of infections when two amplification protocols were used (mini-exon and HSP-70). HSP-70 specific polymerase chain reaction matched the sensitivity of parasite cultivation plus histopathology.
CONCLUSION: The best combination was polymerase chain reaction plus histopathology, which increased diagnostic sensitivity to 94%. Species discrimination by polymerase chain reaction disclosed prevalence of human infections with Leishmania guyanensis of 94% and with Leishmania braziliensis of 6% for this region.

Entities:  

Mesh:

Year:  2011        PMID: 22281902     DOI: 10.1590/s0365-05962011000600012

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  4 in total

1.  American cutaneous leishmaniasis: epidemiological profile of patients treated in Londrina from 1998 to 2009.

Authors:  Rubens Pontello Junior; Airton dos Santos Gon; Alessandra Ogama
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

2.  Polymorphisms in the TOLLIP Gene Influence Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis in the Amazonas State of Brazil.

Authors:  Felipe Jules de Araujo; Luan Diego Oliveira da Silva; Tirza Gabrielle Mesquita; Suzana Kanawati Pinheiro; Wonei de Seixas Vital; Anette Chrusciak-Talhari; Jorge Augusto de Oliveira Guerra; Sinésio Talhari; Rajendranath Ramasawmy
Journal:  PLoS Negl Trop Dis       Date:  2015-06-24

3.  Identification of Leishmania species by high-resolution DNA dissociation in cases of American cutaneous leishmaniasis.

Authors:  John Verrinder Veasey; Ricardo Andrade Zampieri; Rute Facchini Lellis; Thaís Helena Proença de Freitas; Lucile Maria Floeter Winter
Journal:  An Bras Dermatol       Date:  2020-05-15       Impact factor: 1.896

4.  An open label randomized clinical trial comparing the safety and effectiveness of one, two or three weekly pentamidine isethionate doses (seven milligrams per kilogram) in the treatment of cutaneous leishmaniasis in the Amazon Region.

Authors:  Ellen Priscilla Nunes Gadelha; Rajendranath Ramasawmy; Bruna da Costa Oliveira; Nágila Morais Rocha; Jorge Augusto de Oliveira Guerra; George Allan Villa Rouco da Silva; Tirza Gabrielle Ramos de Mesquita; Carolina Chrusciak Talhari Cortez; Anette Chrusciak Talhari
Journal:  PLoS Negl Trop Dis       Date:  2018-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.